Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect

Bone Marrow Transplantation

Volumn 19, Issue 10, 1997, Pages 977-982

  Van Besien, K W ^a   De Lima, M ^a   Giralt, S A ^a   Moore Jr , D F ^b   Khouri, I F ^a   Rondon G ^a   Mehra, R ^a   Andersson, B S ^a   Dyer, C ^a   Cleary, K ^a   Przepiorka, D ^a   Gajewski, J L ^a   Champlin, R E ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Cancer Center of Kansas   (United States)

Author keywords

Allogeneic transplantation; Graft versus lymphoma; Lymphoma; Recurrence

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DONOR; DRUG WITHDRAWAL; FEMALE; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; LYMPHOCYTE; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION;

EID: 17344381435     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700781     Document Type: Article

References (28)

1. Fefer A. Graft-versus-tumor responses: adoptive cellular therapy in bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Oxford, 1994, pp 231-241.
2. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. New Engl J Med 1979; 300: 1068-1073.
3. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
4. Appelbaum FR. Treatment of aggressive non-Hodgkin's lymphoma with marrow transplantation. Marrow Transplant Rev 1993; 3: 1-16.
5. Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050-1055.
6. Kolb H, Schattenberg A, Goldman J et al. Graft-versus leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 1995; 86: 2041-2050.
7. Tricot G, Vesole DH, Jagannath S et al. Graft-versus-myeloma effect: proof of principle. Blood 1996; 87: 1196-1198.
8. Giralt SA, LeMaistre CF, Vriesendorp HM et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol 1994; 12: 1923-1930.
9. Van Besien KW, Khouri IF, Giralt SA et al. Allogeneic bone marrow transplantation for refractory and recurrent low grade lymphoma - the case for aggressive management. J Clin Oncol 1995; 13: 1096-1102.
10. Przepiorka D, Ippoliti C, Giralt S et al. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 449-453.
11. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
12. Van Besien KW, Demuynck H, LeMaistre CF et al. High dose melphalan allows durable engraftment of allogeneic bone marrow. Bone Marrow Transplant 1995; 15: 321-323.
13. Krikorian JG, Portlock CS, Cooney P, Rosenberg SA: Spontaneous regression of non-Hodgkin lymphoma: a report of nine cases. Cancer 1980; 46: 2093-2096.
14. Gaidano G, Carbone A. Aids-related lympomas: from pathogenesis to pathology. Br J Haematol 1995; 90: 235-243.
15. Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994; 5: S29-S35.
16. Smalley RV, Andersen JW, Hawkins MJ et al. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. New Engl J Med 1992; 327: 1336-1341.
17. Kwak LW, Campbell MJ, Czerwinski DK et al. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. New Engl J Med 1992; 327: 1209-1215.
18. Molina I, Nicolini F, Viret F et al. Allogeneic bone marrow transplantation for refractory and recurrent low grade non-Hodgkin's lymphoma. Blood 1995; 86: 209a (Abstr.).
19. van Besien K, Rowlings PA, Sobocinski KA et al. Allogeneic bone marrow transplantation for low grade lymphoma. Blood 1995; 86: 209a (Abstr.).
20. Mandigers C, Raemaekers J, Schattenberg A et al. Allogeneic bone marrow transplantation in patients with relapsed low-grade follicular non-Hodgkin's lymphoma. Blood 1995; 86: 208a (Abstr.).
21. Fielding AK, de Witte T, Reiffers J et al. Allogeneic bone marrow transplantation for low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1995; 15: S96 (Abstr.).
22. Jones RJ, Ambinder RF, Piantadosi S, Santos GW. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 77: 649-653.
23. Schouten HC, Armitage JO, Klassen LW et al. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous transplantation. Bone Marrow Transplant 1989; 4: 119-121.
24. de Lima M, van Besien K, Giralt SA et al. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 19: 121-127.
25. Petersen FB, Appelbaum FR, Bigelow CL et al. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. Bone Marrow Transplant 1989; 4: 483-488.
26. Kolb HJ, de Witte T, Mittermueller J et al. Graft-versus leukemia effect of donor buffy coat transfusion on recurrent leukemia after marrow transplantation. Blood 1993; 82: 214a (Abstr.).
27. Rondón G, Giralt S, Huh Y et al. Complete remission due to graft-versus-leukemia effect against chronic lymphocytic leukemia. Bone Marrow Transplant 1996; 18: 669-672.
28. Rondón G, Khouri I, Giralt S et al. Chimerism following sex-mismatched allogeneic BMT in chronic lymphocytic leukemia (CLL). Blood 1994; 84: 208a (Abstr.).